stockrow
Friday 6 November 2026
Export HCAT’s income statement to Excel — free account
Health Catalyst, Inc.
HCAT Healthcare Health Information Services
Health Catalyst, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $311.1 million, up 1.48% from fiscal 2024.
- Revenue
- −26.3%
- EPS
- +268.8%
- Free cash flow
- +65.6%
- Total debt
- +0.29%
Quarter to September 2026, against a year earlier
1.47
0.03
−2.00%
Follow HCAT
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.54 | 0.30 | 0.50 | 0.48 | |
P/FCF ratio |
0.00 | 0.00 | 22.35 | 24.09 | |
P/Operating CF |
16.85 | 4.98 | 535.20 | (70.06) | |
P/B ratio |
0.68 | 0.67 | 1.46 | 0.90 | |
Price to Tangible BV |
0.00 | 0.00 | 4.38 | 1.56 | |
EV/Sales |
0.72 | 0.45 | 0.67 | 0.76 | |
EV/EBITDA |
62.48 | 11.39 | 22.32 | 23.30 | |
EV/Operating CF |
307.21 | 7.21 | 6.99 | 7.67 | |
EV/FCF |
(10.81) | (50.38) | 29.95 | 37.76 | |
Quick Ratio |
1.73 | 1.56 | 1.58 | 1.54 | |
Current Ratio |
1.89 | 1.69 | 2.70 | 1.70 | |
Net Debt/EBITDA |
6.34 | 25.14 | 24.21 | 0.00 | |
Debt/Assets |
30.49% | 37.21% | 42.80% | 0.00% | |
Debt/Equity |
0.62 | 1.11 | 1.52 | 0.00 | |
Asset Turnover |
0.46 | 0.46 | 0.60 | 0.66 | |
Operating CF/Net income |
(0.11) | (0.17) | (0.01) | (0.05) | |
Capex/Depreciation |
(0.06) | (0.05) | (0.14) | 0.00 | |
Interest Coverage |
(18.85) | (25.75) | (9.75) | 92.85 | |
Research and Development Expense of Revenue |
13.27% | 13.82% | 15.64% | 16.88% | |
Selling, General and Administrative Expense of Revenue |
28.41% | 34.69% | 31.62% | 36.53% | |
Intangible Assets out of Total Assets |
0.57 | 0.44 | 0.19 | 0.26 | |
Share Based Compensation of Revenue |
5.50% | 5.33% | 3.84% | 7.24% | |
Graham Net Nets |
(0.52) | (1.00) | (0.06) | 0.31 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(106.28%) | (292.91%) | (184.92%) | (163.01%) | |
Free Cash Flow Yield |
(12.44%) | (2.94%) | 4.47% | 4.15% | |
Revenue per Share |
1.07 | 0.97 | 0.95 | 0.74 | |
Operating CF per Share |
0.14 | 0.26 | 0.00 | (0.02) | |
Capex per Share |
(0.08) | (0.08) | (0.07) | 0.00 | |
Free Cash Flow per Share |
0.06 | 0.18 | (0.07) | (0.03) | |
Cash per Share |
1.37 | 1.50 | 1.40 | 1.04 | |
Shareholders Equity per Share |
3.52 | 1.90 | 1.36 | 1.92 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.52 | 1.90 | 1.36 | 1.92 | |
Free Cash Flow |
4.33 | 13.02 | (5.17) | (1.92) | |
Working Capital |
79.73 | 74.70 | 156.47 | 54.82 | |
Capital Expenditures |
(5.58) | (5.49) | (5.45) | (0.05) | |
Net Current Asset Value |
(87.56) | (91.74) | (9.39) | 41.13 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.07 | 0.08 | 0.08 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
58.16 | 61.60 | 55.14 | 50.72 | |
Average Payables |
10.40 | 10.32 | 8.64 | 5.74 | |
Average Assets |
680.79 | 651.87 | 487.39 | 412.27 | |
Average Common Equity |
305.49 | 257.48 | 224.19 | 238.75 |
Columns are period end dates · fundamentals updated 5 Nov 2026